Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on May 21, 2026

May 21, 2026

QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration

Indeterminate GlobeNewswire

May 21, 2026

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

Indeterminate GlobeNewswire

May 21, 2026

EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

May 21, 2026

Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer

Indeterminate GlobeNewswire

May 21, 2026

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

Indeterminate GlobeNewswire

May 21, 2026

Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards

Indeterminate GlobeNewswire

May 21, 2026

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference

Indeterminate GlobeNewswire

May 21, 2026

The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do

Indeterminate GlobeNewswire

May 21, 2026

Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes

Indeterminate GlobeNewswire

May 21, 2026

Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval

Indeterminate GlobeNewswire

May 21, 2026

Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th

Indeterminate GlobeNewswire

May 21, 2026

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 21, 2026

Hemab Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 21, 2026

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Indeterminate GlobeNewswire

May 21, 2026

SlimTide Examined: 2026 Consumer-Focused Analysis of Ingredients, Claims, and Label Transparency

Indeterminate GlobeNewswire

May 21, 2026

JavaTide Examined: 2026 Analysis of Ingredients Profile, Dosage Accuracy, and Metabolic Support Claims

Indeterminate GlobeNewswire

May 21, 2026

Biodesix to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 21, 2026

Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2

Indeterminate GlobeNewswire

May 21, 2026

HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

Indeterminate GlobeNewswire

May 21, 2026

Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia

Indeterminate GlobeNewswire